$AIMD
Ainos, Inc. Stock $aimd

$aimd Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224030251 Filed on August 05, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue			$28.56K
YoY Change			-95.51%
Cost Of Revenue	$547.00	$25.37K	$55.82K
YoY Change	-99.38%	-54.54%	-82.5%
Gross Profit	-$547.00	-$25.37K	-$27.26K
YoY Change	-99.14%	-6.93%	-108.58%
Gross Profit Margin			-95.47%
Selling, General & Admin	$1.016M	$1.045M	$618.1K
YoY Change	12.61%	69.03%	-1.43%
% of Gross Profit
Research & Development	$2.022M	$1.979M	$1.671M
YoY Change	18.24%	18.4%	2.22%
% of Gross Profit
Depreciation & Amortization	$1.212M	$1.198M	$1.219M
YoY Change	-1.49%	-1.73%	0.71%
% of Gross Profit
Operating Expenses	$3.038M	$3.024M	$2.289M
YoY Change	16.3%	32.07%	1.21%
Operating Profit	-$3.039M	-$3.049M	-$2.317M
YoY Change	13.56%	31.62%	19.15%
Interest Expense	-$264.6K	-$118.8K	-$33.13K
YoY Change	-697.83%	258.48%	-1069.53%
% of Operating Profit
Other Income/Expense, Net	-$660.8K	-$146.0K	$7.180K
YoY Change	120.12%	-2133.61%	-20.75%
Pretax Income	-$3.699M	-$3.195M	-$2.350M
YoY Change	24.31%	35.97%	20.25%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$3.699M	-$3.195M	-$2.350M
YoY Change	24.31%	35.97%	20.25%
Net Earnings / Revenue			-8228.78%
Basic Earnings Per Share	-$0.33	-$0.49	-$0.58
Diluted Earnings Per Share	-$0.33	-$0.49	-$0.12
COMMON SHARES
Basic Shares Outstanding	7.663M shares	6.284M shares	20.04M shares
Diluted Shares Outstanding	11.28M shares	6.519M shares	4.019M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.157M	$8.014M	$1.361M
YoY Change	117.58%	488.85%	-22.4%
Cash & Equivalents	$5.157M	$8.014M	$1.361M
Short-Term Investments
Other Short-Term Assets	$331.9K	$291.2K	$241.2K
YoY Change	-26.24%	20.7%	-81.07%
Inventory	$160.7K	$166.3K	$528.1K
Prepaid Expenses
Receivables		$9.00	$9.385K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.649M	$8.472M	$2.140M
YoY Change	85.82%	295.92%	-42.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$649.1K	$691.1K	$1.269M
YoY Change	-44.12%	-45.55%	-15.55%
Goodwill
YoY Change
Intangibles	$24.89M	$26.03M
YoY Change	-15.41%
Long-Term Investments
YoY Change
Other Assets	$183.2K	$348.6K	$73.17K
YoY Change	-22.1%	376.48%	-41.32%
Total Long-Term Assets	$25.72M	$27.07M	$31.91M
YoY Change	-16.54%	-15.17%	-13.09%
TOTAL ASSETS
Total Short-Term Assets	$5.649M	$8.472M	$2.140M
Total Long-Term Assets	$25.72M	$27.07M	$31.91M
Total Assets	$31.37M	$35.54M	$34.05M
YoY Change	-7.35%	4.39%	-15.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$750.6K	$738.9K	$429.5K
YoY Change	12.03%	72.05%	-83.47%
Deferred Revenue	$110.1K
YoY Change
Short-Term Debt	$270.0K	$312.0K	$684.0K
YoY Change		-54.39%	-32.51%
Long-Term Debt Due	$3.000M	$4.586M	$0.00
YoY Change	7400.0%		-100.0%
Total Short-Term Liabilities	$4.131M	$5.743M	$1.114M
YoY Change	404.07%	415.78%	-84.07%
LONG-TERM LIABILITIES
Long-Term Debt	$9.000M	$9.000M	$2.500M
YoY Change	70.78%	260.0%	-90.88%
Other Long-Term Liabilities	$216.8K	$83.91K	$37.56K
YoY Change	142.64%	123.4%	105.03%
Total Long-Term Liabilities	$216.8K	$83.91K	$37.56K
YoY Change	142.64%	123.4%	-99.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.131M	$5.743M	$1.114M
Total Long-Term Liabilities	$216.8K	$83.91K	$37.56K
Total Liabilities	$13.35M	$14.83M	$3.651M
YoY Change	116.02%	306.1%	-89.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$48.10M	-$44.40M	-$28.99M
YoY Change	50.48%	53.16%	104.66%
Common Stock	$138.1K	$1.318M	$202.9K
YoY Change	-31.93%	549.52%	-85.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.02M	$20.71M	$30.40M
YoY Change
Total Liabilities & Shareholders Equity	$31.37M	$35.54M	$34.05M
YoY Change	-7.35%	4.39%	-15.75%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$3.699M	-$3.195M	-$2.350M
YoY Change	24.31%	35.97%	20.25%
Depreciation, Depletion And Amortization	$1.212M	$1.198M	$1.219M
YoY Change	-1.49%	-1.73%	0.71%
Cash From Operating Activities	-$1.475M	-$1.974M	-$1.151M
YoY Change	99.34%	71.51%	402.06%
INVESTING ACTIVITIES
Capital Expenditures	$10.14K	$5.850K	-$920.00
YoY Change	-74.65%	-735.87%	-99.78%
Acquisitions
YoY Change
Other Investing Activities	-$8.630K	-$2.670K
YoY Change	-13.7%
Cash From Investing Activities	-$18.79K	-$8.510K	$1.220K
YoY Change	-62.42%	-797.54%	-100.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.482M	9.000M	1.391M
YoY Change	-180.97%	547.12%	155.19%
NET CHANGE
Cash From Operating Activities	-1.475M	-1.974M	-1.151M
Cash From Investing Activities	-18.79K	-8.510K	1.220K
Cash From Financing Activities	-1.482M	9.000M	1.391M
Net Change In Cash	-2.976M	7.017M	241.0K
YoY Change	-386.12%	2812.13%	789.84%
FREE CASH FLOW
Cash From Operating Activities	-$1.475M	-$1.974M	-$1.151M
Capital Expenditures	$10.14K	$5.850K	-$920.00
Free Cash Flow	-$1.485M	-$1.980M	-$1.150M
YoY Change	90.42%	72.16%	-688.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	106502	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	112555	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3000000	usd
CY2023Q4	AIMD	Convertible Debt Fair Value Disclosures Current ConvertibleDebtFairValueDisclosuresCurrent		usd
CY2024Q2	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures		usd
CY2024Q2	AIMD	Other Notes Payable Related Party Noncurrent OtherNotesPayableRelatedPartyNoncurrent		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Revenues Revenues		usd
CY2024Q2	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue		usd
CY2023Q2	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue		usd
	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue		usd
CY2023Q2	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote		usd
	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Inventory Write Down InventoryWriteDown		usd
	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue		usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives		usd
	AIMD	Increase In Refundable Deposits And Other Assets IncreaseInRefundableDepositsAndOtherAssets		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	AIMD	Repayment Of Convertible Notes Payable Related Party RepaymentOfConvertibleNotesPayableRelatedParty		usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
	AIMD	Conversion Of Convertible Notes Payable To Common Stock And Accrued Interest Waived By Convertible Notes Holders ConversionOfConvertibleNotesPayableToCommonStockAndAccruedInterestWaivedByConvertibleNotesHolders		usd
	AIMD	Conversion Of Senior Secured Convertible Notes To Common Stock ConversionOfSeniorSecuredConvertibleNotesToCommonStock		usd
	AIMD	Issuance Of Common Stocks In Exchange Of Vehicle IssuanceOfCommonStocksInExchangeOfVehicle		usd
	AIMD	Account Payable To Purchase Equipment AccountPayableToPurchaseEquipment		usd
CY2024Q2	AIMD	Inventory Writedowns Net Realizable Values InventoryWritedownsNetRealizableValues		usd
	AIMD	Inventory Writedowns Net Realizable Values InventoryWritedownsNetRealizableValues		usd
CY2024Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense		usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense		usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1885628	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	691100	usd
CY2024Q2	AIMD	Convertible Debt Fair Value Disclosures Current ConvertibleDebtFairValueDisclosuresCurrent	1585761	usd
CY2024Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	312000	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	42000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	738936	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1182283	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5743199	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1336838	usd
CY2023Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	2651556	usd
CY2024Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	9000000	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	3000000	usd
CY2024Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	9000000	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	3000000	usd
CY2023Q4	AIMD	Other Notes Payable Related Party Noncurrent OtherNotesPayableRelatedPartyNoncurrent	270000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	83912	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	135829	usd
CY2024Q2	us-gaap	Liabilities Liabilities	14827111	usd
CY2023Q4	us-gaap	Liabilities Liabilities	7394223	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4677787	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4677787	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	73887	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	46778	usd
CY2024Q2	AIMD	Shares Obligated To Issue SharesObligatedToIssue	270	shares
CY2023Q4	AIMD	Shares Obligated To Issue SharesObligatedToIssue	162337	shares
CY2024Q2	AIMD	Common Stock Issuable CommonStockIssuable	3	usd
CY2023Q4	AIMD	Common Stock Issuable CommonStockIssuable	1623	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	65414761	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	62555808	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44395987	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37886155	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-380388	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-270473	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	20712276	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	24447581	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35539387	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31841804	usd
CY2023Q2	us-gaap	Revenues Revenues	28555	usd
	us-gaap	Revenues Revenues	20729	usd
	us-gaap	Revenues Revenues	77719	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	25373	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	55817	usd
	us-gaap	Cost Of Revenue CostOfRevenue	52127	usd
	us-gaap	Cost Of Revenue CostOfRevenue	156665	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	-25373	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	-27262	usd
	us-gaap	Gross Profit GrossProfit	-31398	usd
	us-gaap	Gross Profit GrossProfit	-78946	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1978756	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1671187	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4063404	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3370070	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1044880	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	618149	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2074298	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1380614	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	3023636	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2289336	usd
	us-gaap	Operating Expenses OperatingExpenses	6137702	usd
	us-gaap	Operating Expenses OperatingExpenses	4750684	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3049009	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2316598	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6169100	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4829630	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	118759	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	40311	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	167455	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	49585	usd
	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-138992	usd
CY2024Q2	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote	-66844	usd
	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote	-98412	usd
CY2024Q2	us-gaap	Other Income OtherIncome	39590	usd
CY2023Q2	us-gaap	Other Income OtherIncome	7182	usd
	us-gaap	Other Income OtherIncome	64127	usd
	us-gaap	Other Income OtherIncome	9013	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-146013	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-33129	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-340732	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-40572	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3195022	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2349727	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6509832	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4870202	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-3195022	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2349727	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6509832	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4870202	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6519014	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6519014	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4019030	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4019030	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6145148	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6145148	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4010666	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4010666	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-3195022	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2349727	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6509832	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4870202	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	44646	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	53867	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	109915	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	43806	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3239668	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2403594	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6619747	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4914008	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	22678793	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	850777	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	422374	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-3195022	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-44646	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	20712276	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	32338424	usd
CY2023Q2	AIMD	Stock Issued During Period Value Exchange Stock In Of Vehicle Amount StockIssuedDuringPeriodValueExchangeStockInOfVehicleAmount	48559	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	274789	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	137159	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2349727	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-53867	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	30395337	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	24447581	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2039207	usd
	AIMD	Adjustments To Additional Paid In Capital Related Party Used Computer Equipment Amount AdjustmentsToAdditionalPaidInCapitalRelatedPartyUsedComputerEquipmentAmount	-4428	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1586	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	848077	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6509832	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-109915	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	20712276	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34628006	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34628006	usd
	AIMD	Stock Issued During Period Value Exchange Stock In Of Vehicle Amount StockIssuedDuringPeriodValueExchangeStockInOfVehicleAmount	48559	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	274789	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	357991	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4870202	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-43806	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	30395337	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	30395337	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6509832	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4870202	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2398696	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2423274	usd
	us-gaap	Inventory Write Down InventoryWriteDown	57474	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	848077	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	357991	usd
	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-138992	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-98412	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-446	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-192161	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1271	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10814	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-128355	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	55990	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-573309	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-693975	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3468892	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2578453	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10276	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	71262	usd
	AIMD	Increase In Refundable Deposits And Other Assets IncreaseInRefundableDepositsAndOtherAssets	109516	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-119792	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-71262	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1000000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	9000000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1500000	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	875000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	200000	usd
	AIMD	Repayment Of Convertible Notes Payable Related Party RepaymentOfConvertibleNotesPayableRelatedParty	114026	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	97500	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9777500	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2185974	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-60346	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-28651	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6128470	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-492392	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1885628	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1853362	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8014098	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1360970	usd
	us-gaap	Interest Paid Net InterestPaidNet	39	usd
	us-gaap	Interest Paid Net InterestPaidNet	3122	usd
	AIMD	Conversion Of Convertible Notes Payable To Common Stock And Accrued Interest Waived By Convertible Notes Holders ConversionOfConvertibleNotesPayableToCommonStockAndAccruedInterestWaivedByConvertibleNotesHolders	274789	usd
	AIMD	Conversion Of Senior Secured Convertible Notes To Common Stock ConversionOfSeniorSecuredConvertibleNotesToCommonStock	2039207	usd
	AIMD	Issuance Of Common Stocks In Exchange Of Vehicle IssuanceOfCommonStocksInExchangeOfVehicle	48559	usd
	AIMD	Account Payable To Purchase Equipment AccountPayableToPurchaseEquipment	5848	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zFdNWnDUlbHl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_863_zk7qq86zLcBb">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of condensed financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosures as of the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on various factors, including historical experience, and on various other assumptions that are believed to be reasonable under the circumstances, when these carrying values are not readily available from other sources. Significant items subject to estimates and assumptions include useful lives of property and equipment, valuation of stock option, warrants and convertible notes measured at fair value, and impairment testing of intangible assets. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8014098	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6509832	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44395987	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q2	AIMD	Excess Of Fdic Insured Limits ExcessOfFdicInsuredLimits	4281890	usd
CY2023Q4	AIMD	Excess Of Fdic Insured Limits ExcessOfFdicInsuredLimits	1557487	usd
CY2024Q2	AIMD	Cash Cdic Insured Amount CashCDICInsuredAmount	3000000	twd
CY2024Q2	AIMD	Cash Cdic Insured Amount CashCDICInsuredAmount	93750	usd
CY2024Q2	AIMD	Excess Of Cdic Insured Limits ExcessOfCDICInsuredLimits	3358000	twd
CY2023Q4	AIMD	Excess Of Cdic Insured Limits ExcessOfCDICInsuredLimits	0	twd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	87047	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	92708	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1142	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1208	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	78133	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	73677	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	166322	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	167593	usd
CY2023Q2	AIMD	Inventory Writedowns Net Realizable Values InventoryWritedownsNetRealizableValues	14694	usd
	AIMD	Inventory Writedowns Net Realizable Values InventoryWritedownsNetRealizableValues	57474	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	13897761	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	5963556	usd
CY2024Q2	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote	-66844	usd
	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote	-98412	usd
	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-138992	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1244168	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7388674	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7388674	shares
CY2024Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3749535	shares
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1909810	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	894444	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	0	shares
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	106502	usd
CY2023Q2	us-gaap	Employee Stock Ownership Plan Esop Shares In Esop EmployeeStockOwnershipPlanESOPSharesInESOP	871075	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7332	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	5111	shares
CY2024Q2	AIMD	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAndExercisableNumber	6034	shares
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	422374	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	848077	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	137159	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	357991	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2486290	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M9D
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-3195022	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2349727	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6509832	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4870202	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6519014	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	6519014	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4019030	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4019030	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6145148	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	6145148	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4010666	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4010666	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6956403	shares
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	694443	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6956403	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	694443	shares
CY2024Q2	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	220488	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	87632	usd
CY2023Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	19618	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	39344	usd

Files In Submission

Name	View Source	Status
0001493152-24-030251-index-headers.html	Edgar Link	pending
0001493152-24-030251-index.html	Edgar Link	pending
0001493152-24-030251.txt	Edgar Link	pending
0001493152-24-030251-xbrl.zip	Edgar Link	pending
aimd-20240630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
aimd-20240630_def.xml	Edgar Link	unprocessable
aimd-20240630_lab.xml	Edgar Link	unprocessable
aimd-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
aimd-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AIMD
Ainos, Inc. Stock $aimd

2024 Q3 Form 10-Q Financial Statement

#000149315224030251 Filed on August 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIMD Ainos, Inc. Stock $aimd

2024 Q3 Form 10-Q Financial Statement

#000149315224030251 Filed on August 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIMD
Ainos, Inc. Stock $aimd